FutureCure Health, a health-tech firm, said that it has raised $4 million in Series A investment from investors including RVCF India Growth Fund, Unicorn India Ventures, Kotak Investment Advisors Ltd, and others. FutureCure was founded by Rajneesh Bhandari and Dr Anita Bhandari, a husband-and-wife team of engineers and doctors. According to a statement from the firm, the funds will be utilised to further develop numerous technologies, obtain FDA clearances, and expand globally.
Rajneesh Bhandari said, ”FutureCure is developing cutting-edge technologies to diagnose and treat chronic diseases like migraine, dizziness. FutureCure plans to launch various technologies for migraine patients, including wearable Neuromodulation and Biofeedback device. In addition, the Digital Therapeutics app will help identify the triggers using AI and help manage lifestyle changes. The interactive app will also provide Cognitive-Behavioral Therapy (CBT).”
Anita Bhandari said,” Migraine affects over 12 percent of the global population. The incidence is much higher than diabetes or cardiac disease, especially in the age group of 20 to 50 years, which are the most productive years of a person’s life. Technological interventions by FutureCure will help millions of patients manage their Migraine and other chronic diseases.”
